Prognostic value of body composition and nutritional assessment in recurrent/metastatic squamous cell carcinoma of head and neck (R/M SCCHN) treated with immunotherapy (IO)

被引：0
|
作者：
Vidales Sepulveda, Z. [1 ]
Choulli, M. [2 ]
Fabrego, S. [2 ]
Pallares, N. [3 ]
Santos, N. [3 ]
Llop Serna, S. [1 ]
Brenes Castro, J. [1 ]
Plana Serrahima, M. [4 ]
Juarez Lozano, C. M. [5 ]
Brunet, A. [6 ]
Melero, M. [7 ]
Bermejo, O. [8 ]
Vilajosana, E. [1 ,9 ]
Godino, C. [10 ]
Oliva, M. [11 ]
Arribas, L. [12 ]
机构：
[1] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[2] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Nutr Dept, Lhospitalet De Llobregat, Spain
[3] IDIBELL Bellvitge Biomed Res Inst, Biostat Unit, Lhospitalet De Llobregat, Spain
[4] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Barcelona, Spain
[5] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Radiat Oncol, Barcelona, Spain
[6] Hosp Univ Bellvitge, Otolaryngol Dept, Lhospitalet De Llobregat, Spain
[7] Hosp Univ Bellvitge, Oral & Maxillofacial Surg Dept, Lhospitalet De Llobregat, Spain
[8] Hosp Univ Bellvitge, Plast Surg Dept, Lhospitalet De Llobregat, Spain
[9] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[10] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Med Oncol Dept, Barcelona, Spain
[11] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Moliva Iconcol Net, Barcelona, Spain
[12] Inst Catala Oncol, Clin Nutr Unit, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2072
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
928P
引用
收藏
页码：S585 / S586
页数：2
相关论文
共 50 条
  • [1] Cetuximab with or without sorafenib in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN)
    Gilbert, Jill
    Schell, Michael J.
    Zhao, Xiuhua
    Murphy, Barbara A.
    Tanvetyanon, Tawee
    Hayes, David N.
    Haigentz, Missak
    Saba, Nabil F.
    Nieva, Jorge J.
    Perez, Jimena
    Bishop, Justin A.
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Real-world outcomes for patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab
    Singh, P.
    You, M.
    Lubinga, S.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] A COMPARISON OF PATIENT CHARACTERISTICS TREATED WITH NIVOLUMAB FOR RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN GERMANY AND THE USA
    von der Heyde, E.
    Welslau, M.
    Gauler, T.
    Rothnie, K.
    Waldenberger, D.
    Dietz, A.
    VALUE IN HEALTH, 2019, 22 : S536 - S536
  • [4] Prognostic value of hyponatremia on metastatic or recurrent head and neck squamous cell carcinoma
    Melo Alvim Moreira, C.
    Semedo, P.
    Paiva, R.
    Lobo Martins, S.
    Pais, H.
    Costa, A. L.
    Ribeiro, L.
    Costa, L.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 37 - 37
  • [5] Analysis of HPV and ERCC1 in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
    Mehra, Ranee
    Egloff, Ann Marie
    Li, Shuli
    Yang, Donghua
    Wang, Lin
    Zhu, Fang
    Forastiere, Arlene A.
    Burtness, Barbara
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [8] The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).
    Scheff, Nicole N.
    Nilsen, Marci Lee
    Li, Jinhong
    Harris, Alexandria L.
    Swartz, Andrew
    Hsieh, Ronan Wenhan
    Anderson, Jennifer Lynn
    Ferris, Robert L.
    Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] The humanistic burden reported by patients diagnosed with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) in Europe
    Singh, P.
    Bennett, B.
    Bailey, T.
    Taylor-Stokes, G.
    Hennessy, L.
    Rajkovic, I.
    Contente, M. C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] CORRELATION BETWEEN QUALITY OF LIFE (QOL) OF PATIENTS TREATED WITH NIVOLUMAB IN RECURRENT AND/OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (R/M SCCHN) AND THEIR CAREGIVERS
    Baumstarck, K.
    Even, C.
    Grumberg, V
    Schwartz, D.
    Lahaye, J.
    Pointreau, Y.
    Ceruse, P.
    Babin, E.
    Fayette, J.
    Rondeau, V
    Cotte, F. E.
    Govart, A.
    Salas, S.
    Le Tourneau, C.
    VALUE IN HEALTH, 2023, 26 (12) : S474 - S474
12345